Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.
about
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinomaStrategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantationSystematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma.Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profilingSelection tool alpha-fetoprotein for patients waiting for liver transplantation: How to easily manage a fractal algorithm.Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.A Preoperative Measurement of Serum MicroRNA-125b May Predict the Presence of Microvascular Invasion in Hepatocellular Carcinomas Patients.Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience.Value of MR histogram analyses for prediction of microvascular invasion of hepatocellular carcinomaRadiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified?Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population-based studyTreatment options in hepatocellular carcinoma today.A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.The role of bridging therapy in hepatocellular carcinoma.Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA.Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.Impact of Visceral Obesity on Microvascular Invasion in Hepatocellular Carcinoma.Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion.Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?Twenty years of Milan criteria: how far do we go.Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria.Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion.Expanding the boundaries of Milan.A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging.Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation
P2860
Q26740332-AB8486C9-3854-4711-B9AB-6E393C689D5EQ27005375-7D4B6436-2331-4D34-8229-85F0D178CA38Q34201437-27689048-692A-478C-A180-DB2707DAF5AEQ35501184-AE5FD0EA-6CA5-4DAD-AB51-F2CDEB979FA8Q35895358-2A8A431B-960C-4020-B8C5-F77B93389382Q36731897-35220EB8-4E4E-4161-8C85-9ADF67E95FE3Q36870217-7400C1C0-839D-4B07-A923-2C5600B96A82Q37035208-191C2282-54CA-4DB3-92F2-6A4446B6AAB0Q37078018-17A89CDC-034E-41A5-9A40-13AAB9BAF445Q37317451-5F2CD650-2B7C-4AB5-B1CB-A6F88BBEBEE7Q37580894-4331ECCE-D383-4359-B934-279E1609E4B7Q37698565-6652055A-92CC-49EB-B9D0-9E5D81407FC3Q37863929-D14688C8-7430-4E68-B49B-511405F6F142Q38059620-F699BA24-24BC-46B5-861B-261C7EEC6929Q38181127-15D80BB9-2748-4612-B1FC-FABED0FB392CQ38962965-EC5020BD-729B-4AE3-A40B-8AC05E37D8CFQ39332805-CCAFC882-CE43-4735-B4D7-F214F7DAF556Q39645893-2432B4DF-A4C4-42A3-BDA6-C110305B4EB1Q41879293-460E0D9D-A6EF-4D83-8A27-68CD69E3C04CQ42151173-879F1E75-DB18-4703-84A5-F42A15C218FAQ42333007-2440F344-17CF-43B1-849E-03BB88E3CBA4Q43408290-F5DFA418-F76A-4FD0-B1B1-B2B3C9263665Q46396394-CA2F95BB-B286-4B01-9D9C-4D9ED118C926Q47126426-EFB6669D-6F25-4FDA-85B0-30DCA9279F2EQ52984307-B8E23506-A974-40EE-85DF-8517D491183FQ54209069-1E2E2127-B64C-4792-8D3D-956B0F9F9D1DQ54978814-8960D159-5425-4937-88F4-5232BD4AFADBQ57792485-1D0A380E-58B5-4397-9008-2ACA0FBE45C9
P2860
Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Alpha-fetoprotein and tumour s ...... with hepatocellular carcinoma.
@ast
Alpha-fetoprotein and tumour s ...... with hepatocellular carcinoma.
@en
type
label
Alpha-fetoprotein and tumour s ...... with hepatocellular carcinoma.
@ast
Alpha-fetoprotein and tumour s ...... with hepatocellular carcinoma.
@en
prefLabel
Alpha-fetoprotein and tumour s ...... with hepatocellular carcinoma.
@ast
Alpha-fetoprotein and tumour s ...... with hepatocellular carcinoma.
@en
P2093
P2860
P1476
Alpha-fetoprotein and tumour s ...... with hepatocellular carcinoma.
@en
P2093
Alvaro Koch
Dinesh Ranjan
Jeffrey Gilbert
Patrick P McHugh
Roberto Gedaly
Santiago Vera
P2860
P356
10.1111/J.1477-2574.2009.00128.X
P577
2010-02-01T00:00:00Z